Delphia (USA)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,881
Closed -$178K 439
2022
Q2
$178K Buy
+12,881
New +$178K 0.12% 294